193 related articles for article (PubMed ID: 1851034)
1. Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro.
Faint RW; Mackie IJ; Machin SJ
Br J Haematol; 1991 Apr; 77(4):539-45. PubMed ID: 1851034
[TBL] [Abstract][Full Text] [Related]
2. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor.
Salvemini D; de Nucci G; Gryglewski RJ; Vane JR
Proc Natl Acad Sci U S A; 1989 Aug; 86(16):6328-32. PubMed ID: 2548208
[TBL] [Abstract][Full Text] [Related]
3. LY 83583 (6-anilino-5,8-quinolinedione) blocks nitrovasodilator-induced cyclic GMP increases and inhibition of platelet activation.
Mülsch A; Lückhoff A; Pohl U; Busse R; Bassenge E
Naunyn Schmiedebergs Arch Pharmacol; 1989 Jul; 340(1):119-25. PubMed ID: 2552329
[TBL] [Abstract][Full Text] [Related]
4. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
5. Comparative platelet inhibitory effects of human neutrophils and lymphocytes.
Nicolini FA; Wilson AC; Mehta P; Mehta JL
J Lab Clin Med; 1990 Aug; 116(2):147-52. PubMed ID: 2168463
[TBL] [Abstract][Full Text] [Related]
6. An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
Radomski MW; Palmer RM; Moncada S
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5193-7. PubMed ID: 1695013
[TBL] [Abstract][Full Text] [Related]
7. Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: comparison with ATP, adenosine and guanosine.
Vuorinen P; Laustiola KE
Pharmacol Toxicol; 1992 Oct; 71(4):289-93. PubMed ID: 1333596
[TBL] [Abstract][Full Text] [Related]
8. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.
De La Cruz JP; Páez MV; Carmona JA; De La Cuesta FS
Br J Pharmacol; 1999 Dec; 128(7):1538-44. PubMed ID: 10602334
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the L-arginine:nitric oxide pathway in human platelets.
Radomski MW; Palmer RM; Moncada S
Br J Pharmacol; 1990 Oct; 101(2):325-8. PubMed ID: 1701676
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of cyclic GMP production in cultured endothelial cells of the pig by bradykinin, adenosine diphosphate, calcium ionophore A23187 and nitric oxide.
Boulanger C; Schini VB; Moncada S; Vanhoutte PM
Br J Pharmacol; 1990 Sep; 101(1):152-6. PubMed ID: 2178013
[TBL] [Abstract][Full Text] [Related]
11. [The effect of triflusal on human platelet aggregation and secretion: the role of nitric oxide].
Sánchez de Miguel L; Montón M; Mar Arriero M; Guerra JI; Jiménez A; González-Fernández F; García-Durán M; Bellver T; Rico L; Romero J; Gómez J; Núñez A; Marcos P; Ayala R; Farré J; Casado S; López-Farré A
Rev Esp Cardiol; 2000 Feb; 53(2):205-11. PubMed ID: 10734753
[TBL] [Abstract][Full Text] [Related]
12. Nitrovasodilators and cGMP inhibit human platelet activation.
Doni MG; Alexandre A; Padoin E; Bertoncello S; Deana R
Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321
[TBL] [Abstract][Full Text] [Related]
13. Platelet inhibition by an L-arginine-derived substance released by IL-1 beta-treated vascular smooth muscle cells.
Durante W; Schini VB; Scott-Burden T; Junquero DC; Kroll MH; Vanhoutte PM; Schafer AI
Am J Physiol; 1991 Dec; 261(6 Pt 2):H2024-30. PubMed ID: 1661096
[TBL] [Abstract][Full Text] [Related]
14. L-arginine modulates aggregation and intracellular cyclic 3,5-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative thiol agent.
Anfossi G; Russo I; Massucco P; Mattiello L; Perna P; Tassone F; Trovati M
Thromb Res; 1999 Jun; 94(5):307-16. PubMed ID: 10379819
[TBL] [Abstract][Full Text] [Related]
15. Effect of trilinolein on cyclic nucleotide formation in human platelets: relationship with its antiplatelet effect and nitric oxide synthesis.
Shen YC; Hong CY
Br J Pharmacol; 1995 Sep; 116(1):1644-8. PubMed ID: 8564231
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effect of amlodipine: a possible mechanism through a nitric oxide-mediated process.
Chou TC; Li CY; Yen MH; Ding YA
Biochem Pharmacol; 1999 Nov; 58(10):1657-63. PubMed ID: 10535758
[TBL] [Abstract][Full Text] [Related]
17. N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets.
Anfossi G; Russo I; Massucco P; Mattiello L; Cavalot F; Trovati M
Eur J Clin Invest; 2001 May; 31(5):452-61. PubMed ID: 11380598
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
Bode-Böger SM; Böger RH; Galland A; Frölich JC
Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
[TBL] [Abstract][Full Text] [Related]
19. Effects of two preparations of 75-mg extended-release aspirin on platelet aggregation, prostanoids and nitric oxide production in humans.
de la Cruz JP; Guerrero A; González-Correa JA; Márquez E; Nacle I; Sánchez de la Cuesta F
Eur J Clin Pharmacol; 2002 Jan; 57(11):775-80. PubMed ID: 11871383
[TBL] [Abstract][Full Text] [Related]
20. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
Liao CH; Cheng JT; Teng CM
Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]